Law.comScott Grahamhttps://images.law.com/contrib/content/uploads/sites/292/2022/08/Corrin-Drakulich-767×633.jpgSkilled in the Art/Pharmaceuticals/Technology Media and Telecom/News/Boston/Southeast/Intellectual Property/Patent Litigation/Biotech and Pharmac / Law.com
Fish Saves Infant Nutrition Patents From a Premature Death + Cisco and Desmarais Block Bid for $371 – A generic competitor called Exela Pharma Sciences patents on intravenous cysteine hydrochloride frivolous. Judge Maryellen Noreika called them valid and infringed. …
